Genomics

Dataset Information

A pilot study of neoadjuvant nivolumab, ipilimumab and intralesional oncolytic virotherapy for HER2-negative breast cancer


ABSTRACT: A pilot study of neoadjuvant nivolumab, ipilimumab and intralesional oncolytic virotherapy for HER2-negative breast cancer

PROVIDER: PRJNA980388 | ENA |

REPOSITORIES: ENA